S. 1692 · 117th Congress
Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CapitoSponsor15 cosponsors · 10 D, 4 R, 1 I
D
Menendez
DS
D
Stabenow
RW
R
Wicker
BC
D
Casey
CH
R
Hyde-Smith
JT
D
Tester
JH
R
Hoeven
KS
D
Sinema
TT
R
Tillis
CV
D
Van Hollen
RB
D
Blumenthal
AK
D
Klobuchar
AK
I
King
JS
D
Shaheen
GP
D
Peters3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2021 This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults.
What it does: CRS summary · Introduced in Senate · May 19, 2021
Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2021
This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.
Additionally, the Centers for Medicare & Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021
Latest action (May 19, 2021): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: May 19, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.